Publikationen, an denen er mitarbeitet Antonio Jesús López Gambero (12)

2024

  1. Sex-based differences in growth-related IGF1 signaling in response to PAPP-A2 deficiency: comparative effects of rhGH, rhIGF1 and rhPAPP-A2 treatments

    Biology of Sex Differences, Vol. 15, Núm. 1

2022

  1. Dietary administration of D-chiro-inositol attenuates sex-specific metabolic imbalances in the 5xFAD mouse model of Alzheimer's disease

    Biomedicine and Pharmacotherapy, Vol. 150

  2. Endocrine and Metabolic Impact of Oral Ingestion of a Carob-Pod-Derived Natural-Syrup-Containing D-Pinitol: Potential Use as a Novel Sweetener in Diabetes

    Pharmaceutics, Vol. 14, Núm. 8

  3. Pharmacokinetics and Endocrine Effects of an Oral Dose of D-Pinitol in Human Fasting Healthy Volunteers

    Nutrients, Vol. 14, Núm. 19

  4. d-Pinitol promotes tau dephosphorylation through a cyclin-dependent kinase 5 regulation mechanism: A new potential approach for tauopathies?

    British Journal of Pharmacology, Vol. 179, Núm. 19, pp. 4655-4672

2021

  1. A negative energy balance is associated with metabolic dysfunctions in the hypothalamus of a humanized preclinical model of alzheimer’s disease, the 5xfad mouse

    International Journal of Molecular Sciences, Vol. 22, Núm. 10

  2. Energy sensors in drug addiction: A potential therapeutic target

    Addiction Biology, Vol. 26, Núm. 2

  3. Recombinant igf-1 induces sex-specific changes in bone composition and remodeling in adult mice with pappa2 deficiency

    International Journal of Molecular Sciences, Vol. 22, Núm. 8

2020

  1. Imbalance of endocannabinoid/lysophosphatidylinositol receptors marks the severity of alzheimer’s disease in a preclinical model: A therapeutic opportunity

    Biology, Vol. 9, Núm. 11, pp. 1-22

  2. Peroxisome Proliferator-Activated Receptors: Experimental Targeting for the Treatment of Inflammatory Bowel Diseases

    Frontiers in Pharmacology, Vol. 11

  3. The biomedical uses of inositols: A nutraceutical approach to metabolic dysfunction in aging and neurodegenerative diseases

    Biomedicines, Vol. 8, Núm. 9

2018

  1. The adiponectin promoter activator NP-1 induces high levels of circulating TNFα and weight loss in obese (fa/fa) Zucker rats

    Scientific Reports, Vol. 8, Núm. 1